Bo Li

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Signaling Pathway

Childhood Cancer

Long Noncoding Rna

Top Venues

Cancer gene therapy

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Bo Xu, Yonggang Wei, Fei Liu, Lian Li, Siqi Zhou, Yufu Peng, Bo Li
Long noncoding RNA CERS6-AS1 modulates glucose metabolism and tumor progression in hepatocellular carcinoma by promoting the MDM2/p53 signaling pathway. Cell death discovery 8 (1) (2022)
Siqi Zhou, Lian Li, Ming Zhang, Yang Qin, Bo Li
The function of brother of the regulator of imprinted sites in cancer development. Cancer gene therapy (2022)
Liangliang Xu, Lian Li, Peng Wang, Ming Zhang, Yanfang Zhang, Xiangyong Hao, Lvnan Yan, Bo Li, Tianfu Wen, MingQing Xu
Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center. Gut and liver 13 (6) (2020)